<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<body bgcolor="#FFFFFF">
<page>
<p align="center"><font size="2" face="serif"><b>UNITED STATES<br>
</b></font><b><font face="serif" size="4">SECURITIES AND EXCHANGE COMMISSION<br>
</font></b><font size="2" face="serif"><b>Washington, D.C. 20549 </b></font></p>
<p align="center"><b><font face="serif" size="4">FORM 8-K </font></b></p>
<p align="center"><font size="2" face="serif">________________</font></p>
<p align="center"><font size="2" face="serif"><b>CURRENT REPORT</b></font></p>
<p align="center"><font size="2" face="serif"><b>PURSUANT TO SECTION 13 OR 15(d)<br>OF THE SECURITIES EXCHANGE ACT OF 1934 </b></font></p>
<p align="center"><font size="2" face="serif"><b>November 14, 2006<br>
</b></font><font size="2" face="serif"><b>Date of Report (Date of Earliest Event Reported)</b></font></p>
<p align="center"><font size="2" face="serif"><b>________________________</b></font></p>
<p align="center"><font size="2" face="serif"><b><font face="serif" size="4">POLYMEDIX, INC.</font></b></font></p>
<p align="center"><font size="2" face="serif"><b>(Exact name of registrant as specified in its charter) </b></font></p>
<p align="center"><font size="2" face="serif">_____________________</font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr bgcolor="#FFFFFF">
<td align="center" valign="top"><font size="2" face="serif"><b>Delaware</b></font></td>
<td width="2%" align="left" valign="top">&nbsp;</td>
<td width="30%" align="center"><font size="2" face="serif"><b>000-51895</b></font></td>
<td width="2%" align="left" valign="top">&nbsp;</td>
<td width="30%" align="center" valign="top"><font size="2" face="serif"><b>27-0125925</b></font></td>
</tr>
<tr bgcolor="#FFFFFF">
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(State or other jurisdiction<br>of incorporation)</font></b></font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(Commission File Number)</font></b></font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(IRS Employer<br>
Identification No.)</font></b></font></td>
</tr>
<tr>
<td align="left" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="left" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="left" valign="top"><font size="2" face="serif">&nbsp;</font></td>
</tr>
<tr bgcolor="#FFFFFF">
<td align="center" valign="top"><font size="2" face="serif"><b>3701 Market Street</b></font><br><font size="2" face="serif"><b>Philadelphia, PA</b></font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="left" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="center" valign="bottom"><font size="2" face="serif"><b>19104</b></font></td>
</tr>
<tr bgcolor="#FFFFFF">
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(Address of principal executive offices)</font></b></font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="left" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="left" valign="top">&nbsp;</td>
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(Zip Code)</font></b></font></td>
</tr>
</table>
<p align="center"><font size="2" face="serif"><b>215-966-6227<br>
</b></font><b><font face="serif" size="1">(Registrant&#8217;s
telephone number, including area code) </font></b></p>
<p align="center"><font size="2" face="serif"><b>Not Applicable<br>
</b></font><b><font face="serif" size="1">(Former name or address, if changed since last report) </font></b></p>
<p align="center"><font size="2" face="serif">____________________</font></p>
<p align="left"><font size="2" face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>
</tr>
</table>
<br>
<p align="center"><font size="2" face="serif"></font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p><a name="p?"></a></p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%"><font size="2" face="serif"><b>Item 8.01.</b></font></td>
    <td><font size="2" face="serif"><b>Other Events</b></font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">On November 14, 2006, PolyMedix, Inc. (the &#8220;Company&#8221;)
        held its Annual Meeting of Stockholders (the &#8220;Meeting&#8221;).
    At the Meeting, the following proposals were considered:</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">1. To elect directors to the Board of Directors
        for a term of one (1) year and until his successor is duly elected and
    qualified. Each of the nominees was elected by the margin indicated:</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%">&nbsp;</td>
    <td align="center"><font size="2" face="serif">Nominee</font></td>
    <td width="15%" align="center"><font size="2" face="serif">Number of Shares</font><br>
    <font size="2" face="serif">Voted For</font></td>
    <td width="15%" align="center"><font size="2" face="serif">Number of Shares</font><br>
    <font size="2" face="serif">Withheld</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Mr. Nicholas Landekic </font>
    </td>
    <td align="center"><font size="2" face="serif">13,620,208</font></td>
    <td align="center"><font size="2" face="serif">53</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Mr. Frank Slattery, Jr.</font>
      </td>
    <td align="center"><font size="2" face="serif">13,620,208</font></td>
    <td align="center"><font size="2" face="serif">53</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Mr. Frank M. DeLape</font>
      </td>
    <td align="center"><font size="2" face="serif">13,620,208</font></td>
    <td align="center"><font size="2" face="serif">53</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Dr. William N. Kelley</font>
      </td>
    <td align="center"><font size="2" face="serif">13,620,208</font></td>
    <td align="center"><font size="2" face="serif">53</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Dr. Michael E. Lewis</font>
      </td>
    <td align="center"><font size="2" face="serif">13,620,208</font></td>
    <td align="center"><font size="2" face="serif">53</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Mr. I. Wistar Morris,
III</font>
</td>
    <td align="center"><font size="2" face="serif">13,600,208</font></td>
    <td align="center"><font size="2" face="serif">20,053</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Mr. Shaun F. O&#8217;Malley</font>
      </td>
    <td align="center"><font size="2" face="serif">13,620,208</font></td>
    <td align="center"><font size="2" face="serif">53</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td colspan="3"><font size="2" face="serif">2. To approve an amendment to the Company&#8217;s
        Certificate of Incorporation to classify the Board of Directors into
        three classes with each class having a staggered three-year term, beginning
        at the Annual Meeting of Stockholders in 2007. The amendment was not
        approved as it failed to receive the required vote of 75% of the Company&#8217;s
    outstanding stock.</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
</table>


<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%">&nbsp;</td>
    <td width="30%" align="center"><font size="2" face="serif">Number of Shares Voted For</font></td>
    <td width="30%" align="center"><font size="2" face="serif">Number of Shares Voted Against</font></td>
    <td width="30%" align="center"><font size="2" face="serif">Abstentions</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center"><font size="2" face="serif">12,504,261</font>
      </td>
    <td align="center"><font size="2" face="serif">287,000</font></td>
    <td align="center"><font size="2" face="serif">829,000</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td colspan="3" align="left"><font size="2" face="serif">3. To approve an amendment
        to the Company&#8217;s 2005 Omnibus Equity Compensation Plan, increasing
        the maximum number of shares of common stock available for issuance under
        the Plan from 1,500,000 shares to 4,000,000 shares. The amendment was
    approved by the margin indicated:</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center"><font size="2" face="serif">Number of Shares Voted For</font></td>
    <td align="center"><font size="2" face="serif">Number of Shares Voted Against</font></td>
    <td align="center"><font size="2" face="serif">Abstentions</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center"><font size="2" face="serif">11,866,176</font></td>
    <td align="center"><font size="2" face="serif">1,568,085</font></td>
    <td align="center"><font size="2" face="serif">186,000</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td colspan="3" align="left"><font size="2" face="serif">4. To ratify the appointment
        of Deloitte &amp; Touche LLP as the Company&#8217;s independent registered
        public accounting firm for the fiscal year ending December 31, 2006.
        The ratification of the appointment of the independent registered public
    accounting firm was approved by the margin indicated:</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
    <td align="center">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center"><font size="2" face="serif">Number of Shares Voted For</font></td>
    <td align="center"><font size="2" face="serif">Number of Shares Voted Against</font></td>
    <td align="center"><font size="2" face="serif">Abstentions</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center"><font size="2" face="serif">13,620,221</font></td>
    <td align="center"><font size="2" face="serif">0</font>
    </td>
    <td align="center"><font size="2" face="serif">40</font></td>
  </tr>
</table>

<p align="center"><font face="serif" size="2"></font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p align="center"><font size="2" face="serif"><b>SIGNATURE</b></font></p>
<p align="left"><font size="2" face="serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
 undersigned hereunto duly authorized.</font></p>
 <div style="margin-left: 50%"><p align="left"><font size="2" face="serif">POLYMEDIX, INC.<br>
<br>
<u>/s/ Edward F. Smith&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
Edward F. Smith<br>
Vice President, Finance and Chief Financial Officer</font></p>
</div>
<p align="left"><font size="2" face="serif">November 15, 2006</font></p>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b415794_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 13793}]
{"company-data": {"conformed-name": "POLYMEDIX INC", "cik": "0001341843", "assigned-sic": "2834", "irs-number": "000000000"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51895", "film-number": "061220384"}, "business-address": {"street1": "C/O POLYMEDIX INC", "street2": "3701 MARKET STREET STE 442", "city": "PHILADELPHIA", "state": "PA", "zip": "19104", "phone": "2159666199"}, "mail-address": {"street1": "C/O POLYMEDIX INC", "street2": "3701 MARKET STREET STE 442", "city": "PHILADELPHIA", "state": "PA", "zip": "19104"}, "former-company": {"former-conformed-name": "BTHC II ACQUISITION CORP", "date-changed": "20051019"}}
Prepared and filed by St Ives Financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
November 14, 2006
Date of Report (Date of Earliest Event Reported)
________________________
POLYMEDIX, INC.
(Exact name of registrant as specified in its charter)
_____________________
Delaware
000-51895
27-0125925
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
3701 Market Street
Philadelphia, PA
19104
(Address of principal executive offices)
(Zip Code)
215-966-6227
(Registrant's
telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01.
Other Events
On November 14, 2006, PolyMedix, Inc. (the "Company")
        held its Annual Meeting of Stockholders (the "Meeting").
    At the Meeting, the following proposals were considered:
1. To elect directors to the Board of Directors
        for a term of one (1) year and until his successor is duly elected and
    qualified. Each of the nominees was elected by the margin indicated:
Nominee
Number of Shares
Voted For
Number of Shares
Withheld
Mr. Nicholas Landekic
13,620,208
53
Mr. Frank Slattery, Jr.
13,620,208
53
Mr. Frank M. DeLape
13,620,208
53
Dr. William N. Kelley
13,620,208
53
Dr. Michael E. Lewis
13,620,208
53
Mr. I. Wistar Morris,
III
13,600,208
20,053
Mr. Shaun F. O'Malley
13,620,208
53
2. To approve an amendment to the Company's
        Certificate of Incorporation to classify the Board of Directors into
        three classes with each class having a staggered three-year term, beginning
        at the Annual Meeting of Stockholders in 2007. The amendment was not
        approved as it failed to receive the required vote of 75% of the Company's
    outstanding stock.
Number of Shares Voted For
Number of Shares Voted Against
Abstentions
12,504,261
287,000
829,000
3. To approve an amendment
        to the Company's 2005 Omnibus Equity Compensation Plan, increasing
        the maximum number of shares of common stock available for issuance under
        the Plan from 1,500,000 shares to 4,000,000 shares. The amendment was
    approved by the margin indicated:
Number of Shares Voted For
Number of Shares Voted Against
Abstentions
11,866,176
1,568,085
186,000
4. To ratify the appointment
        of Deloitte & Touche LLP as the Company's independent registered
        public accounting firm for the fiscal year ending December 31, 2006.
        The ratification of the appointment of the independent registered public
    accounting firm was approved by the margin indicated:
Number of Shares Voted For
Number of Shares Voted Against
Abstentions
13,620,221
0
40
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
 undersigned hereunto duly authorized.
POLYMEDIX, INC.
/s/ Edward F. Smith
Edward F. Smith
Vice President, Finance and Chief Financial Officer
November 15, 2006